These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 30071644)
1. Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy. Domagala A; Fidyt K; Bobrowicz M; Stachura J; Szczygiel K; Firczuk M Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30071644 [TBL] [Abstract][Full Text] [Related]
2. Targeting the lysosome in cancer. Piao S; Amaravadi RK Ann N Y Acad Sci; 2016 May; 1371(1):45-54. PubMed ID: 26599426 [TBL] [Abstract][Full Text] [Related]
3. Lysosomes as mediators of drug resistance in cancer. Zhitomirsky B; Assaraf YG Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313 [TBL] [Abstract][Full Text] [Related]
4. Lysosomes as a Target of Anticancer Therapy. Trybus W; Trybus E; Król T Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768500 [TBL] [Abstract][Full Text] [Related]
5. Lysosomes as Oxidative Targets for Cancer Therapy. Dielschneider RF; Henson ES; Gibson SB Oxid Med Cell Longev; 2017; 2017():3749157. PubMed ID: 28757908 [TBL] [Abstract][Full Text] [Related]
6. Lysosomal membrane permeabilization and cell death. Wang F; Gómez-Sintes R; Boya P Traffic; 2018 Dec; 19(12):918-931. PubMed ID: 30125440 [TBL] [Abstract][Full Text] [Related]
7. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer. Shirbhate E; Singh V; Mishra A; Jahoriya V; Veerasamy R; Tiwari AK; Rajak H Mini Rev Med Chem; 2024; 24(15):1449-1468. PubMed ID: 38343053 [TBL] [Abstract][Full Text] [Related]
8. Lysosomal membrane permeabilization as a cell death mechanism in cancer cells. Serrano-Puebla A; Boya P Biochem Soc Trans; 2018 Apr; 46(2):207-215. PubMed ID: 29472365 [TBL] [Abstract][Full Text] [Related]
9. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486 [TBL] [Abstract][Full Text] [Related]
16. Dual targeting of tumor cell energy metabolism and lysosomes as an anticancer strategy. Paunovic V; Kosic M; Misirkic-Marjanovic M; Trajkovic V; Harhaji-Trajkovic L Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(4):118944. PubMed ID: 33383091 [TBL] [Abstract][Full Text] [Related]
17. Lysosomes in Cancer-At the Crossroad of Good and Evil. Eriksson I; Öllinger K Cells; 2024 Mar; 13(5):. PubMed ID: 38474423 [TBL] [Abstract][Full Text] [Related]
18. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Ali SM; Olivo M Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096 [TBL] [Abstract][Full Text] [Related]
19. Subcellular Hsp70 Inhibitors Promote Cancer Cell Death via Different Mechanisms. Park SH; Baek KH; Shin I; Shin I Cell Chem Biol; 2018 Oct; 25(10):1242-1254.e8. PubMed ID: 30057298 [TBL] [Abstract][Full Text] [Related]
20. Lysosomes in programmed cell death pathways: from initiators to amplifiers. Kavčič N; Pegan K; Turk B Biol Chem; 2017 Mar; 398(3):289-301. PubMed ID: 28002019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]